Access to new drugs for rare disorders in Canada

Eitemau Tebyg

• Health technology assessment of new drugs for rare disorders in Canada: impact of disease prevalence and cost
  gan: Rawson, Nigel S. B.
  Cyhoeddwyd: (2017)
• Leading Causes of Mortality and Prescription Drug Coverage in Canada and New Zealand
  gan: Rawson, Nigel S. B.
  Cyhoeddwyd: (2020)
• Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?
  gan: Rawson, Nigel SB, et al.
  Cyhoeddwyd: (2017)
• National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare"
  gan: Rawson, Nigel S. B.
  Cyhoeddwyd: (2020)
• Importation of drugs into the United States from Canada
  gan: Rawson, Nigel S.B., et al.
  Cyhoeddwyd: (2017)